[Advances in treatment of fragile X syndrome]
- PMID: 21082495
- DOI: 10.1016/s0028-3843(14)60141-9
[Advances in treatment of fragile X syndrome]
Abstract
The fragile X syndrome (FRAX) is the most common familial form of mental retardation. The incidence is estimated at 1 in 4000 males. The leading symptom of the syndrome is mental retardation, with accompanying behavioural problems. About 25-35% of affected persons meet the criteria of autism. The behavioural problems involve attention problems, hyperactivity, tactile defensiveness, speech problems (echolalia), aggression, emotional problems, depression, anxiety, and stereotypic movements. There is no causal treatment and management is mainly symptomatic. Many specialists should be involved in this process. Behavioural and educational therapy is indicated. The basic step is identification of the child's problems. Its goal is to promote development of the child's abilities. Pharmacological intervention should be accompanied by supporting methods. The diagnosis of FRAX involves the entire family. The family members should be offered genetic counselling and the possibility of diagnostic DNA analysis.
Similar articles
-
[Fragile X syndrome--child's and parent's problem].Psychiatr Pol. 2011 May-Jun;45(3):357-65. Psychiatr Pol. 2011. PMID: 22232966 Review. Polish.
-
Lessons from fragile X regarding neurobiology, autism, and neurodegeneration.J Dev Behav Pediatr. 2006 Feb;27(1):63-74. doi: 10.1097/00004703-200602000-00012. J Dev Behav Pediatr. 2006. PMID: 16511373 Review.
-
Fragile X: treatment of hyperactivity.Pediatrics. 1997 May;99(5):753. doi: 10.1542/peds.99.5.753. Pediatrics. 1997. PMID: 9157389 No abstract available.
-
The fragile-X syndrome. On the way to a behavioural phenotype.Br J Psychiatry. 1992 Jan;160:24-35. doi: 10.1192/bjp.160.1.24. Br J Psychiatry. 1992. PMID: 1544010 Review.
-
Molecular screening for fragile X syndrome in children with unexplained intellectual disability and/or autistic behaviour.Folia Med (Plovdiv). 2022 Feb 28;64(1):27-32. doi: 10.3897/folmed.64.e60518. Folia Med (Plovdiv). 2022. PMID: 35851904
Cited by
-
Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.Oncotarget. 2016 Nov 15;7(46):75394-75406. doi: 10.18632/oncotarget.12215. Oncotarget. 2016. PMID: 27683117 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical